Ofatumumab for the treatment of COVID-19-associated autoimmune encephalitis: A case report. Wang Z, Du X, Wang Q, Zhang Y, et al. J Neuroimmunol 2025;403:578590.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Z, Du X, Wang Q, Zhang Y, et al. Ofatumumab for the treatment of COVID-19-associated autoimmune encephalitis: A case report. J Neuroimmunol 2025;403:578590.
PMID: 40154217